DIN 02479567 — RIVASTIGMINE PATCH 15 13.3 MG
RIVASTIGMINE PATCH 15 is a patch of Rivastigmine marketed by PHARMASCIENCE INC. The full Rivastigmine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02479567
- Brand name
- RIVASTIGMINE PATCH 15
- Active ingredient
- Rivastigmine
- Strength
- 13.3 MG
- Dosage form
- PATCH
- Route
- TRANSDERMAL
- Manufacturer
- PHARMASCIENCE INC
- Health Canada status
- DORMANT
- Drug class
- Cholinesterase Inhibitor (carbamate-type)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Rivastigmine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02336715 | APO-RIVASTIGMINE | 1.5 MG | CAPSULE | APOTEX INC | MARKETED |
| 02336723 | APO-RIVASTIGMINE | 3 MG | CAPSULE | APOTEX INC | MARKETED |
| 02336731 | APO-RIVASTIGMINE | 4.5 MG | CAPSULE | APOTEX INC | MARKETED |
| 02336758 | APO-RIVASTIGMINE | 6 MG | CAPSULE | APOTEX INC | MARKETED |
| 02427567 | AURO-RIVASTIGMINE | 1.5 MG | CAPSULE | AURO PHARMA INC | DORMANT |
| 02427575 | AURO-RIVASTIGMINE | 3 MG | CAPSULE | AURO PHARMA INC | DORMANT |
| 02427583 | AURO-RIVASTIGMINE | 4.5 MG | CAPSULE | AURO PHARMA INC | DORMANT |
| 02427591 | AURO-RIVASTIGMINE | 6 MG | CAPSULE | AURO PHARMA INC | DORMANT |
| 02242115 | EXELON | 1.5 MG | CAPSULE | KNIGHT THERAPEUTICS INC. | MARKETED |
| 02245240 | EXELON | 2 MG | SOLUTION | KNIGHT THERAPEUTICS INC. | MARKETED |
| 02242116 | EXELON | 3 MG | CAPSULE | KNIGHT THERAPEUTICS INC. | MARKETED |
| 02242117 | EXELON | 4.5 MG | CAPSULE | KNIGHT THERAPEUTICS INC. | MARKETED |
| 02242118 | EXELON | 6 MG | CAPSULE | KNIGHT THERAPEUTICS INC. | MARKETED |
| 02302853 | EXELON PATCH 10 | 9.5 MG | PATCH | KNIGHT THERAPEUTICS INC. | MARKETED |
| 02432803 | EXELON PATCH 15 | 13.3 MG | PATCH | KNIGHT THERAPEUTICS INC. | MARKETED |
| 02302845 | EXELON PATCH 5 | 4.6 MG | PATCH | KNIGHT THERAPEUTICS INC. | MARKETED |
| 02485362 | JAMP RIVASTIGMINE | 1.5 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED |
| 02485370 | JAMP RIVASTIGMINE | 3 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED |
| 02485389 | JAMP RIVASTIGMINE | 4.5 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED |
| 02485397 | JAMP RIVASTIGMINE | 6 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED |
| 02552256 | JAMP RIVASTIGMINE CAPSULES | 1.5 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED |
| 02552264 | JAMP RIVASTIGMINE CAPSULES | 3 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED |
| 02552272 | JAMP RIVASTIGMINE CAPSULES | 4.5 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED |
| 02552280 | JAMP RIVASTIGMINE CAPSULES | 6 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED |
| 02401614 | MED-RIVASTIGMINE | 1.5 MG | CAPSULE | GENERIC MEDICAL PARTNERS INC | MARKETED |
| 02401622 | MED-RIVASTIGMINE | 3 MG | CAPSULE | GENERIC MEDICAL PARTNERS INC | MARKETED |
| 02401630 | MED-RIVASTIGMINE | 4.5 MG | CAPSULE | GENERIC MEDICAL PARTNERS INC | MARKETED |
| 02401649 | MED-RIVASTIGMINE | 6 MG | CAPSULE | GENERIC MEDICAL PARTNERS INC | MARKETED |
| 02423421 | MYLAN-RIVASTIGMINE PATCH 10 | 9.5 MG | PATCH | MYLAN PHARMACEUTICALS ULC | MARKETED |
| 02423413 | MYLAN-RIVASTIGMINE PATCH 5 | 4.6 MG | PATCH | MYLAN PHARMACEUTICALS ULC | MARKETED |
| 02479559 | RIVASTIGMINE PATCH 10 | 9.5 MG | PATCH | PHARMASCIENCE INC | DORMANT |
| 02479540 | RIVASTIGMINE PATCH 5 | 4.6 MG | PATCH | PHARMASCIENCE INC | DORMANT |
| 02426307 | SANDOZ RIVASTIGMINE PATCH 10 | 9.5 MG | PATCH | SANDOZ CANADA INCORPORATED | MARKETED |
| 02426293 | SANDOZ RIVASTIGMINE PATCH 5 | 4.6 MG | PATCH | SANDOZ CANADA INCORPORATED | MARKETED |